Isofraxidin exerts anti-diabetic, antilipidemic, and antioxidant effects and protects renal tissues via inhibition of NF-ĸB in Streptozotocin-induced diabetic rats
Authors:
- 20 January 2022
- journal article
- research article
- Published by Springer Nature in Molecular & Cellular Toxicology
- p. 1-11
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Signaling in Innate Immunity and InflammationCold Spring Harbor Perspectives in Biology, 2012
- Inhibition of Aldose Reductase byGentiana luteaExtractsExperimental Diabetes Research, 2012
- Blocking NF-κB: An Inflammatory IssueProceedings of the American Thoracic Society, 2011
- Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative reviewDiabetes, Obesity and Metabolism, 2010
- Induction of diabetes by Streptozotocin in ratsIndian Journal of Clinical Biochemistry, 2007
- Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older MenDiabetes Care, 2005
- Molecular Recognition and Docking AlgorithmsAnnual Review of Biophysics, 2003
- Diabetes, oxidative stress, and antioxidants: A reviewJournal of Biochemical and Molecular Toxicology, 2003
- Glucose-6-phosphatase inhibitors for the treatment of Type 2 diabetesExpert Opinion on Therapeutic Patents, 2001
- Inflammation, free radicals, and antioxidantsNutrition, 1996